Have a feature idea you'd love to see implemented?
Let us know!
TXMD TherapeuticsMD Inc
Price (delayed)
$1.33
Market cap
$15.34M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.26
Enterprise value
$16.07M
TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women
Highlights
TXMD's quick ratio has surged by 57% year-on-year
TXMD's debt is down by 14% year-on-year and by 3.8% since the previous quarter
The net income has plunged by 105% YoY but it is up by 46% from the previous quarter
The company's EPS has shrunk by 103% YoY but it has surged by 51% QoQ
The equity has contracted by 3.4% YoY and by 2.1% from the previous quarter
Key stats
What are the main financial stats of TXMD
Market
Valuations
Earnings
Shares outstanding
11.53M
Market cap
$15.34M
Enterprise value
$16.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.57
Price to sales (P/S)
9.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.07
Revenue
$1.6M
EBIT
-$3.47M
EBITDA
-$2.42M
Free cash flow
-$7.12M
Per share
Balance sheet
Liquidity
EPS
-$0.26
Free cash flow per share
-$0.62
Book value per share
$2.35
Revenue per share
$0.14
TBVPS
$3.05
Total assets
$39.55M
Total liabilities
$12.46M
Debt
$5.78M
Equity
$27.09M
Working capital
$6.18M
Debt to equity
0.21
Current ratio
2.03
Quick ratio
1.4
Net debt/EBITDA
-0.3
Margins
Efficiency
Dividend
EBITDA margin
-151.6%
Gross margin
100%
Net margin
-207.8%
Operating margin
-379.2%
Return on assets
-8%
Return on equity
-11.8%
Return on invested capital
-11.1%
Return on capital employed
-10.3%
Return on sales
-217.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TXMD stock price
How has the TherapeuticsMD stock price performed over time
Intraday
-0.75%
1 week
-8.9%
1 month
-15.56%
1 year
-52.33%
YTD
-40.89%
QTD
-19.88%
Financial performance
How have TherapeuticsMD's revenue and profit performed over time
Revenue
$1.6M
Gross profit
$1.6M
Operating income
-$6.05M
Net income
-$3.32M
Gross margin
100%
Net margin
-207.8%
TherapeuticsMD's operating income has shrunk by 115% YoY but it has increased by 13% QoQ
The net income has plunged by 105% YoY but it is up by 46% from the previous quarter
TXMD's revenue has dropped by 98% year-on-year but it has soared by 60% since the previous quarter
The gross profit has plunged by 98% YoY but it has soared by 60% from the previous quarter
Growth
What is TherapeuticsMD's growth rate over time
Valuation
What is TherapeuticsMD stock price valuation
P/E
N/A
P/B
0.57
P/S
9.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.07
The company's EPS has shrunk by 103% YoY but it has surged by 51% QoQ
The stock's price to book (P/B) is 29% less than its last 4 quarters average of 0.8
The equity has contracted by 3.4% YoY and by 2.1% from the previous quarter
TXMD's revenue has dropped by 98% year-on-year but it has soared by 60% since the previous quarter
TXMD's price to sales (P/S) is 46% lower than its last 4 quarters average of 17.7 and 8% lower than its 5-year quarterly average of 10.5
Efficiency
How efficient is TherapeuticsMD business performance
TXMD's return on assets has dropped by 107% year-on-year but it is up by 42% since the previous quarter
TherapeuticsMD's ROE has plunged by 105% YoY but it has increased by 45% from the previous quarter
The ROIC has plunged by 103% YoY but it has increased by 46% from the previous quarter
The company's return on sales has surged by 65% QoQ
Dividends
What is TXMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TXMD.
Financial health
How did TherapeuticsMD financials performed over time
TherapeuticsMD's current ratio has soared by 69% YoY
TXMD's quick ratio has surged by 57% year-on-year
TXMD's debt is 79% smaller than its equity
TXMD's debt is down by 14% year-on-year and by 3.8% since the previous quarter
TXMD's debt to equity is down by 13% year-on-year and by 4.5% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.